
Genetic Medicine with Small Molecules
Serna Bio is developing small molecules to modulate RNA function, unlocking the potential to treat diseases driven by biology intractable by other modalities. Serna Bio is a Y Combinator company (Winter 2021). YC-listed status: Active.